DUBLIN--(BUSINESS WIRE)--The "Global Periodontal Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.
The market was valued at US$ 259.5 Mn in 2016, and is expected to reach US$ 580.5 Mn by 2025, expanding at a CAGR of 9.2% from 2017 to 2025.
On the basis of treatment, the global periodontal therapeutics market has been segmented in terms of systemic antibiotics and local antibiotics. Systemic antibiotics held the largest share due to product affordability, availability and high market penetration would further drive the periodontal therapeutics market during the forecast period.
North America dominated the global periodontal therapeutics market in the base year 2016 due to the higher awareness regarding periodontal diseases as compared to other regions. Moreover, prevalence of periodontal diseases due to sedentary lifestyle, efficient reimbursement scenario and rising geriatric population are the major driving factors for the rise in the periodontal therapeutics market in North America.
Asia Pacific has emerged as the most lucrative market for periodontal therapeutics market due to large patient pool, growing healthcare infrastructure and expenditure.
The periodontal therapeutics market currently possesses only few companies having their products marketed. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America.
Key Market Movements:
- An increase in antibiotic-resistant bacteria has created interest in using inexpensive, safe, and highly bactericidal/virucidal antiseptics in periodontal therapy.
- Rising geriatric population has resulted in the growth in the prevalence of periodontal diseases, which is boosting the demand for periodontal therapeutics gloabally.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Periodontal Therapeutics Market Analysis
Chapter 4 Global Periodontal Therapeutics Market Analysis, by Therapeutic Type
Chapter 5 Global Periodontal Therapeutics Market, by Geography
Chapter 6 Company Profiles
- Den-Mat Holdings, LLC
- Dexcel Pharma
- Galderma S.A.
- Kaken Pharmaceutical Co., Ltd.
- Valeant Pharmaceuticals International, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/4xmn8z/global_580?w=4